| Investor Name | Invest Money | Lead Investor | Propotion | |
|---|---|---|---|---|
| Dainippon Sumitomo Pharma | - | - | - | Detail |
| Eventide | - | - | - | Detail |
| Fidelity Management and Research Company | - | - | - | Detail |
| Palantir Technologies | - | - | - | Detail |
| Patient Square Capital | - | - | - | Detail |
| RTW Investments | - | - | - | Detail |
| SoftBank Capital | - | - | - | Detail |
| Suvretta Capital Management | - | - | - | Detail |
| Viking Global Investors | - | - | - | Detail |
| Announced Date | Round | Money Raised | Investors | |
|---|---|---|---|---|
| May 1, 2014 | Private Equity(PE) | $ 93M | Dexcel Pharma,QVT Financial,etc. | Detail |
| Nov 13, 2018 | Private Equity(PE) | $ 200M | Dexcel Pharma,Founders Fund,etc. | Detail |
| Jul 13, 2016 | Private Equity(PE) | $ 500M | Viking Global Investors | Detail |
| Aug 9, 2017 | Private Equity(PE) | $ 1.10B | Founders Fund,SoftBank Vision Fund | Detail |